News | August 02, 2011

PET Census: Slower But Continued Growth in PET Patient Studies (2008 to 2010)

PET Census: Slower But Continued Growth in PET Patient Studies (2008 to 2010)

August 2, 2011 – An estimated 1.7 million clinical positron emission tomography (PET) patient studies were performed in the United States in 2010, according to a report just released by IMV Medical Information Division. These PET studies were performed in 2,085 hospital and non-hospital sites, using fixed or mobile PET/computed tomography (CT) or PET scanners.

“The estimated 1,744,000 clinical PET patient studies performed in 2010 represent a 14.7 percent increase over IMV’s estimate of 1,520,800 patient studies performed in 2008, for an average annual growth rate of 7.1 percent over the two years,” said Lorna Young, senior director of market research at IMV. “This represents a slowing in the annual growth rate for PET patient studies, as the average annual rate between 2005 and 2008 was 10.4 percent. However, the annual 7 percent rate for procedures is still a significant growth rate, in an era of increased scrutiny of third-party insurers in their pre-authorization processes.”

Currently, PET technology is utilized primarily for oncology applications, which comprise 95 percent of the PET studies. Neurology and cardiology applications make up the remaining 5 percent, which are likely to become a larger proportion of the studies to be performed, as other radiopharmaceutical tracers, such as PET agents for Alzheimer’s, become approved for clinical use.

“In parallel with the continued evolution of the clinical utility of PET, the number of sites using fixed PET technology is increasing access to PET imaging. Although the number of sites performing PET imaging using fixed or mobile PET increased only 4 percent from 2,000 sites in 2008 to the current 2,085 sites, the mix of sites using fixed units versus mobile PET services has dramatically shifted. Over half of the sites, 1,150 sites, now use fixed PET imaging units, compared to one-third of the sites that were doing PET imaging back in 2003. With this increased access, the median waiting time for a scheduled outpatient appointment at sites using fixed or mobile PET or PET/CT scanners is four days, down from seven days in 2001,” Young said.

“Also, we see a sizable shift in sites using fixed PET/CTs compared to fixed PET scanners. When PET/CT came into the market around 2003, it was adopted rapidly, due to its unparalleled capability to image both anatomical structures and metabolic activity. In 2003, one-third of the installed base was PET/CT scanners, but now, about 90 percent of the fixed units are PET/CTs,” Young said.

“The market for PET scanners was affected by the general economic downturn in 2008. That, coupled with the near-completion of the replacement of the PET-only scanners with PET/CTs, may result in a slow recovery for unit sales. However, about 45 percent of the PET imaging sites currently use mobile services, and they may purchase their first fixed unit as they grow their volume and referrals. Newly introduced technology such as PET/magnetic resonance (MR) may stimulate the demand for additional units in the larger PET centers. Over the next few years, about half of the PET scanner demand will come from first buyers, who are primarily mobile users, about one-third will be replacement buyers and the remaining purchases will be for additional units.”

The report describes trends in PET and PET/CT patient studies by procedure type, PET and PET/CT installed base by manufacturer and year of installation, planned purchases and market scenarios for unit sales through 2015, radiopharmaceutical utilization and expenditures by supplier, and site operations characteristics. Other highlights include:

The top five PET oncology applications are for respiratory, breast cancer, lymphoma and colorectal cancer.

Ninety-four percent of the PET patient studies used radiopharmaceuticals purchased from an outside supplier and 6 percent were obtained from cyclotrons on site.

The five states with the highest PET patient study volume are Florida, California, New York, Texas and Pennsylvania.

IMV’s 2011 PET and PET/CT Census Database provides comprehensive profiles of the identified PET imaging sites in the United States. The database can be licensed by qualified subscribers and includes contact and site-specific information. IMV's 2011 PET Imaging Market Summary Report is available with the database license, or as a separate purchase.

For more information: www.PETReport.imvinfo.com

Related Content

News | PET-CT | February 06, 2019
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and pat
ImaginAb Enrolls First Patient in Phase II PET Agent Clinical Trial
News | Radiopharmaceuticals and Tracers | January 30, 2019
ImaginAb Inc. announced the enrollment of the first patient in the Phase II clinical trial of the company’s CD8+ T Cell...
FDA Clears United Imaging Healthcare uExplorer Total-Body Scanner
Technology | PET-CT | January 23, 2019
January 23, 2019 — United Imaging Healthcare (United Imaging) announced U.S.
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Siemens Healthineers Showcases syngo Virtual Cockpit for More Flexible Workforce Management
News | Teleradiology | November 25, 2018
During the 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 25-30...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...